Related Experiment Video
Updated: Jul 7, 2026
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 25, 2008
Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge
M Ferran1, F Gallardo, A M Ferrer
1Department of Dermatology, Hospital del Mar-IMAS, Passeig Marítim 25-29, 08003 Barcelona, Spain. mferran@imas.imim.es
Insights
Myeloid dendritic cell leukaemia is a rare cancer. This case highlights diagnostic challenges, especially with skin involvement, emphasizing the need for detailed immunophenotypic analysis to confirm the diagnosis.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Myeloid or type 1 dendritic cell leukaemia is an exceptionally rare hematologic malignancy.
- It presents a unique immunophenotype, closely resembling plasmacytoid dendritic cells and acute myelogenous leukemia.
Observation:
- A case report of a 77-year-old male with myeloid dendritic cell leukaemia involving the skin is presented.
- Initial clinical and histopathological findings suggested a CD4+/CD56+ haematodermic neoplasm.
- Cutaneous infiltration posed diagnostic challenges based on routine methods.
Findings:
- Extensive immunophenotypic studies on peripheral blood blasts confirmed the diagnosis.
- Leukaemic cells expressed specific myeloid dendritic cell markers.
- This confirmed the initial suspicion despite initial diagnostic ambiguity.
Implications:
- The case underscores the diagnostic difficulties associated with cutaneous manifestations of myeloid dendritic cell leukaemia.
- Accurate diagnosis relies on comprehensive immunophenotypic analysis beyond routine histopathology.
- This highlights the importance of advanced diagnostic techniques in rare hematologic neoplasms.
Abstract:
Myeloid or type 1 dendritic cell leukaemia is an exceedingly rare haematopoietic neoplasm characterized by a specific immunophenotypic profile close to plasmacytoid dendritic cell and acute myelogenous leukaemia. A 77-year-old man presenting specific cutaneous infiltration by myeloid dendritic cell leukaemia is reported. The clinical features as well as the cutaneous histopathological and immunohistochemical features led to the initial diagnosis of CD4+/CD56+ haematodermic neoplasm. However, extensive immunophenotypic studies performed from peripheral blood blasts disclosed that leukaemic cells expressed myeloid dendritic cell markers, confirming the diagnosis. The diagnostic difficulties of specific cutaneous involvement by myeloid dendritic cell leukaemia on the basis of routine histopathological and immunohistochemical features are highlighted.